 |
vestronidase alfa-vjbk |
|---|---|
| Trade Name | Mepsevii |
| Orphan Indication | Mucopolysaccharidosis VII (MPS VII, Sly Syndrome) |
| USA Market Approval | USA |
| USA Designation Date | 2012-02-16 00:00:00 |
| Sponsor | Ultragenyx Pharmaceutical, Inc.;60 Leveroni Court;Novato, California, 94949 |
